Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Feb 12, 2025

SELL
$0.0 - $25.59 $0 - $2.3 Million
-90,000 Closed
0 $0
Q1 2024

Feb 12, 2025

BUY
$13.58 - $17.36 $1.13 Million - $1.44 Million
83,178 Added 1219.26%
90,000 $1.42 Billion
Q4 2023

Feb 12, 2025

BUY
$10.11 - $16.54 $68,970 - $112,835
6,822 New
6,822 $110 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Bit Capital Gmb H Portfolio

Follow Bit Capital Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Bit Capital Gmb H with notifications on news.